RxDoctor Payments Data

Nelson Keller, DPM

Podiatrist · Grafton, VANPI 1558377408

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.8%), food and beverage and entertainment — rather than concentrated in one kind of arrangement. Stryker accounts for 69.6% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $4,711 and has fallen 83.1% since, to $796 in 2025. Among podiatrist clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,936in general payments, 2019–2025

Across 306 payments — averaging $55.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$12K
  • Smith+Nephew$2K
  • Paragon 28, Inc.$1K
  • Misonix Inc$572
  • Bioventus LLC$500
  • Kerecis Limited$394
  • plus $706 from 13 others

What the payments were for

  • Travel & lodging$8,76952%
  • Food & beverage$8,14748%
  • Entertainment$210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,936 in reported general payments places this provider in the 90th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$980,391
Medicare patients
817
Services billed
6,613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin119$1,848
Methylprednisolone231$1,338
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen117$983
Diclofenac Sodium111$817
CeftriaxoneCeftriaxone Sodium28$813
Cephalexin117$675
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen82$672
Terbinafine Hcl48$669
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav37$441
Ciprofloxacin Hcl31$304
Clindamycin Hcl32$264
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim38$225
Amitriptyline Hcl11$187
Prednisone28$179
Oxycodone Hcl12$135

Paid to pharmacies, not to this prescriber.

Other podiatrist in Grafton

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →